G01N 33/507
Pancreatic cells
Official title: {Pancreatic cells}
G01N33/507 (Pancreatic cells) appears on 91 US grants and 204 published applications in this corpus.
Search patents in G01N- Granted patents
- 91
- Published applications
- 204
- Assignees
- 106
- Inventors
- 355
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 5 |
| 2004 | 0 | 7 |
| 2005 | 0 | 12 |
| 2006 | 4 | 11 |
| 2007 | 2 | 14 |
| 2008 | 3 | 6 |
| 2009 | 3 | 9 |
| 2010 | 2 | 7 |
| 2011 | 6 | 13 |
| 2012 | 4 | 6 |
| 2013 | 5 | 11 |
| 2014 | 5 | 11 |
| 2015 | 8 | 14 |
| 2016 | 4 | 14 |
| 2017 | 6 | 13 |
| 2018 | 7 | 10 |
| 2019 | 10 | 14 |
| 2020 | 3 | 3 |
| 2021 | 4 | 9 |
| 2022 | 2 | 7 |
| 2023 | 3 | 1 |
| 2024 | 1 | 2 |
| 2025 | 6 | 2 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Organ models26 May 2026US 12,638,440 B2The Penn State Research Foundation
- Microfluidic trapping chip and uses thereof for culture and assay of cell clusters and objects26 Aug 2025US 12,397,294 B2President and Fellows of Harvard College
- Cell-based ZNT8 assay22 Jul 2025US 12,366,570 B2The Johns Hopkins University
- Diagnostic methods, therapeutic agents and uses thereof3 Jun 2025US 12,320,798 B2Metabolon, Inc.
- Methods and kits for identifying cancer treatment targets29 Apr 2025US 12,286,623 B2The Regents of the University of California
- P21-activated kinase 4 inhibition and e-cadherin expression inducer and screening method therefor13 Aug 2026US 2026/0235580 A1Seoul National University Hospital
- Methods and uses of microbiome compositions, components, or metabolites for treating insulin-associated diseases2 Apr 2026US 2026/0091067 A1MarvelBiome, Inc.
- Methods and Kits for Identifying Cancer Treatment Targets8 Jan 2026US 2026/0009022 A1The Regents of the University of California
- Methods and agents for decreasing insulin resistance12 Jun 2025US 2025/0186379 A1Whitehead Institute for Biomedical Research
- Transdifferentiation of Pancreatic Duct Cells Into Beta-Like Cells8 May 2025US 2025/0144152 A1Joslin Diabetes Center, Inc.
Most cited
By later US patents
- Endoderm cells from human embryonic stem cells169US 7,326,572 B2Geron Corporation · 2008
- Islet cells from human embryonic stem cells152US 7,033,831 B2Geron Corporation · 2006
- Methods and reagents for treating glucose metabolic disorders34US 7,396,809 B1Curis, Inc. · 2008
- In vitro pancreatic differentiation of pluripotent mammalian cells28US 9,790,470 B2Cambridge Enterprise Limited · 2017
- Methods for identifying compounds for treating diabetes mellitus20US 7,381,523 B2BioCrine AB · 2008